AMGN compared with HALO: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

HALOHalozyme Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

HALOHalozyme Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only HALO 32

LLYEli Lilly and Company ("Lilly")customer

ABOSAcumen Pharmaceuticals, Inc. ("Acumen")customer

ARGXargenx BVBA ("argenx")customer

SKYESkye Bioscience, Inc. ("Skye Bioscience")

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

customer

28 more · HALO chain ›

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

HALOHalozyme Therapeutics, Inc.

103.73▼−15.64%· post 104.00

ClosedNov 6 '26

Mkt cap$11.8BRevenue$493MQ3 FY26Revenue$1.4BFY25

Compare

ClosedNov 6 '26

AMGNAmgen Inc

HALOHalozyme Therapeutics, Inc.

460.55▲+0.06%post 460.42

Price

103.73▼−15.64%post 104.00

$249.0B

Mkt cap

$11.8B

Q3 FY26$10.4B

Revenue

$493MQ3 FY26

FY25$36.8B

Revenue

$1.4BFY25

AMGN460.55▲+0.06%vsHALO103.73▼−15.64%ClosedNov 6 '26